New drug may quiet the hoarseness after botox for voice spasms
NCT ID NCT05123053
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether amifampridine can reduce temporary voice weakness and breathiness that often occurs in the first few weeks after Botox injections for spasmodic dysphonia (a voice disorder). 18 adults who regularly get Botox for this condition took part. The goal was to see if the drug could ease these short-term side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VOCAL WEAKNESS(POST-BOTOX INJECTION) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Augusta University
Augusta, Georgia, 30912, United States